Identification and Mapping of DNA Binding Proteins Target Sequences in Long Genomic Regions by Two-Dimensional EMSA

Total Page:16

File Type:pdf, Size:1020Kb

Identification and Mapping of DNA Binding Proteins Target Sequences in Long Genomic Regions by Two-Dimensional EMSA Research Reports Identification and mapping of DNA binding proteins target sequences in long genomic regions by two-dimensional EMSA Igor P. Chernov, Sergey B. Akopov, Lev G. Nikolaev, and Eugene D. Sverdlov BioTechniques 41:90-96 (July 2006) doi 10.2144/000112197 Specific binding of nuclear proteins, in particular transcription factors, to target DNA sequences is a major mechanism of genome functioning and gene expression regulation in eukaryotes. Therefore, identification and mapping specific protein target sites (PTS) is necessary for understanding genomic regulation. Here we used a novel two-dimensional electrophoretic mobility shift assay (2D- EMSA) procedure for identification and mapping of 52 PTS within a 563-kb human genome region located between the FXYD5 and TZFP genes. The PTS occurred with approximately equal frequency within unique and repetitive genomic regions. PTS belonging to unique sequences tended to group together within gene introns and close to their 5′ and 3′ ends, whereas PTS located within repeats were evenly distributed between transcribed and intragenic regions. INTRODUCTION mechanism of genome functioning identification of a whole set of specific and regulation in eukaryotes (5), that PTS and grouping them according to The publication of the human makes identification and mapping their functional role and interactions genome sequence (1,2) and sequences of specific protein target sites (PTS) with other regulatory units. The result of other metazoan genomes greatly necessary for understanding genomic should be a protein binding map of facilitated positioning and analysis of regulation. To date, several approaches extended genomic regions or even various genomic functional elements to unbiased mapping of PTS have been whole genomes, ideally a dynamic and first of all coding sequences (3,4). proposed and used. The most widely map depending on cell origin, environ- At the same time, a complete functional used is a chromatin immunopre- mental conditions, and other factors. annotation of sequenced eukaryotic cipitation-on-a-chip (ChIP-on-chip) Recently, we proposed experi- genomes is supposed to include technique that allowed to map target mental approaches for identification positions of all noncoding regulatory sites for the NF-κB (6) and CREB and mapping of nuclear matrix binding elements. Unfortunately, experi- (7) transcription factors across human regions (S/MARs) (14) within a 1-Mb mental data on genomic positions of a chromosome 22 and the Sp1, c-Myc, human chromosome 19 locus between multitude of regulatory sequences, like and p53 factors across human chromo- the FXYD5 and COX7A1 markers enhancers, promoters, transcription somes 21 and 22 (8). Another experi- (15). The locus contains 45 Reference terminators, and replication origins, are mental approach named DamID (9) Sequence (16) genes expressed with very limited, especially at the whole was recently used for mapping GAGA different tissue specificities and therefore genome level. In general, most genomic (10), Myc, Max, and Mad/Mnt target could be a good model for the study regulatory elements (e.g., enhancers) sites across the whole Drosophila of the mammalian genome regulatory are gene-, tissue-, or cell-specific, and genome (11). It should be noted that network. Here we present an approach prediction of these elements by compu- the both techniques are applicable for high-throughput identification and tational methods is difficult and not only to mapping binding sites of well- mapping of a multitude of PTS within always reliable. Therefore, the devel- characterized transcription factors. a given genomic region. Using this opment of high-throughput experi- Computational identification of approach, we mapped 52 sequences mental approaches to identification PTS is, in turn, strongly limited by the capable of specifically binding Jurkat and mapping of genomic functional lack of experimental data necessary cell nuclear proteins within a 563-kb elements is highly desirable. for development of algorithms and long FXYD5-TZFP human chromosome Specific binding of nuclear proteins validation of the results (12,13). A 19 region, a fragment of the FXYD5- to target DNA sequences is a major general approach should include COX7A1 locus mentioned above. Russian Academy of Sciences, Moscow, Russia 90 ı BioTechniques ı www.biotechniques.com Vol. 41 ı No. 1 ı 2006 Research Reports MATERIALS AND METHODS itated as described (21). To increase nuclear protein extracts (26). Recently, the specificity of selection, the above we proposed a two-dimensional variant 2D-EMSA procedure was repeated of EMSA (2D-EMSA) that allowed Basic Protocols twice. Finally, 2 μL polyacrylamide gel us to identify and map binding sites of Growth and transformation of eluate were PCR-amplified (20 cycles the CTCF transcription factor within a Escherichia coli cells, preparation of of 94°C for 20 s, 60°C for 60 s, and 1-Mb human genome region (21). Here ® plasmid DNA, agarose gel electropho- 72°C for 90 s) and cloned in a pGEM - we present a modification of 2D-EMSA resis, electrophoretic mobility shift assay T vector (Promega, Madison, WI, USA) that allows one to obtain and clone DNA (EMSA), and other standard manipula- according to the manufacturer’s recom- fragments capable of binding nuclear tions were performed as described (17). mendations. White colonies (184) were extract proteins of given cells, with the selected and arrayed on a 96-well micro- pattern of the fragments probably being plate. The selected clones were checked � Cells and Nuclear Extract by PCR, and those lacking inserts or producing more than one PCR product A Jurkat cells (acute T cell leukemia, (double inserts) were discarded. TIB-152; ATCC, Manassa, VA, USA) were grown in suspension at 37°C �� One-Dimensional EMSA ���������� and 5% CO2 in RPMI-1640 supple- mented with 10% fetal calf serum, up 6 For EMSA, inserts of individual to approximately 2 × 10 /mL. Nuclear clones were labeled by PCR as extract was isolated as previously described above and purified by described (18) with modifications (19). electrophoresis in a 5% polyacryl- amide gel. EMSA was done essen- Preparation of a Short-Fragment tially as described above with a Library 50,000 counts per minute (cpm) probe, 1 μg nuclear extract protein, and 1 μg DNA of cosmids R30072, R28588, poly(dI-dC)*poly(dI-dC). For compe- F19410, R30879, F24108, F16632, tition experiments, an excess of an R26667, F12426, R28461, F14121, unlabeled probe was added. R31396, F25451, R31076, R28052, ���������������������������������������������� and P1-derived artificial chromosome Sequencing, Computer Analysis, (PAC) PC28130 (kindly provided by A. and Mapping Olsen, Lawrence Livermore National B C Laboratory, Livermore, CA) was Sequencing was done with a ABI isolated and digested with restriction Prism® BigDye™ Terminator v. 3.1 endonucleases Sau3A and Csp6I, kit using an ABI Prism 3100-Avant™ ligated with the library primer 5′-ACT automated sequencer (all from Applied TGAGCTCGAGTATCCATGAACA- Biosystems, Foster City, CA, USA). 3′, and PCR-amplified with the same The sequences obtained were mapped primer as described previously (14,20). by comparison with those deposited in GenBank® using the BLAST (22) Two-Dimensional EMSA server at the National Center for Biotechnology Information (NCBI; For two-dimensional EMSA www.ncbi.nlm.nih.gov/BLAST). The (2D-EMSA), a pool of short DNA data were further analyzed using the Figure 1. The principle and results of two- fragments of a 563-kb FXYD5-TZFP University of California, Santa Cruz dimensional electrophoretic mobility shift region of human chromosome 19 was (UCSC) Human Genome Browser assay (2D-EMSA). (A) General scheme of 2D- EMSA. DNA-protein complexes were initially radioactively labeled by PCR with the (genome.ucsc.edu) (23). separated in a nondenaturing one-dimension library primer and purified as described polyacrylamide gel, and after disruption of the previously (21). The 2D-EMSA was complexes, the DNA fragments released were performed generally as described (21), RESULTS separated in a two-dimension sodium dodecyl sulfate (SDS)-containing gel. The area of spots but instead of purified DNA binding corresponding to target DNA sequences is out- protein, 2.5 μg Jurkat cell nuclear EMSA is one of the most widely lined by the dashed line. (B) The result of 2D- extract protein was added to the initial used methods to explore interactions EMSA with nuclear extract from Jurkat cells EMSA reaction. between DNA and nuclear proteins. The and DNA fragments representing the FXYD5- The gel was then autoradiographed EMSA approach was initially proposed TZFP region of human chromosome 19. (C) Electrophoretic comparison of input DNA frag- overnight, the area containing PTS (see for quantifying interactions between ments with protein target sites (PTS) selected Figure 1A) was excised, cut into small DNA and purified proteins (24,25) and by 2D-EMSA. The most pronounced bands are pieces, and DNA was eluted and precip- was later adapted for crude cellular or marked by arrows. 92 ı BioTechniques ı www.biotechniques.com Vol. 41 ı No. 1 ı 2006 Research Reports characteristic of these cells. Using this outlined by a dashed line (Figure 1A) is Inserts of 120 clones were labeled with approach, we identified and mapped supposed to contain a majority of such 32P, and their ability to specifically bind several tens of potential nuclear protein fragments. nuclear proteins was tested by one- target sequences across an approxi- dimensional EMSA, as described
Recommended publications
  • Screening and Identification of Hub Genes in Bladder Cancer by Bioinformatics Analysis and KIF11 Is a Potential Prognostic Biomarker
    ONCOLOGY LETTERS 21: 205, 2021 Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker XIAO‑CONG MO1,2*, ZI‑TONG ZHANG1,3*, MENG‑JIA SONG1,2, ZI‑QI ZHOU1,2, JIAN‑XIONG ZENG1,2, YU‑FEI DU1,2, FENG‑ZE SUN1,2, JIE‑YING YANG1,2, JUN‑YI HE1,2, YUE HUANG1,2, JIAN‑CHUAN XIA1,2 and DE‑SHENG WENG1,2 1State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine; 2Department of Biotherapy, Sun Yat‑Sen University Cancer Center; 3Department of Radiation Oncology, Sun Yat‑Sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China Received July 31, 2020; Accepted December 18, 2020 DOI: 10.3892/ol.2021.12466 Abstract. Bladder cancer (BC) is the ninth most common immunohistochemistry and western blotting. In summary, lethal malignancy worldwide. Great efforts have been devoted KIF11 was significantly upregulated in BC and might act as to clarify the pathogenesis of BC, but the underlying molecular a potential prognostic biomarker. The present identification mechanisms remain unclear. To screen for the genes associated of DEGs and hub genes in BC may provide novel insight for with the progression and carcinogenesis of BC, three datasets investigating the molecular mechanisms of BC. were obtained from the Gene Expression Omnibus. A total of 37 tumor and 16 non‑cancerous samples were analyzed to Introduction identify differentially expressed genes (DEGs). Subsequently, 141 genes were identified, including 55 upregulated and Bladder cancer (BC) is the ninth most common malignancy 86 downregulated genes. The protein‑protein interaction worldwide with substantial morbidity and mortality.
    [Show full text]
  • Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
    521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7).
    [Show full text]
  • The Human Genome Project
    TO KNOW OURSELVES ❖ THE U.S. DEPARTMENT OF ENERGY AND THE HUMAN GENOME PROJECT JULY 1996 TO KNOW OURSELVES ❖ THE U.S. DEPARTMENT OF ENERGY AND THE HUMAN GENOME PROJECT JULY 1996 Contents FOREWORD . 2 THE GENOME PROJECT—WHY THE DOE? . 4 A bold but logical step INTRODUCING THE HUMAN GENOME . 6 The recipe for life Some definitions . 6 A plan of action . 8 EXPLORING THE GENOMIC LANDSCAPE . 10 Mapping the terrain Two giant steps: Chromosomes 16 and 19 . 12 Getting down to details: Sequencing the genome . 16 Shotguns and transposons . 20 How good is good enough? . 26 Sidebar: Tools of the Trade . 17 Sidebar: The Mighty Mouse . 24 BEYOND BIOLOGY . 27 Instrumentation and informatics Smaller is better—And other developments . 27 Dealing with the data . 30 ETHICAL, LEGAL, AND SOCIAL IMPLICATIONS . 32 An essential dimension of genome research Foreword T THE END OF THE ROAD in Little has been rapid, and it is now generally agreed Cottonwood Canyon, near Salt that this international project will produce Lake City, Alta is a place of the complete sequence of the human genome near-mythic renown among by the year 2005. A skiers. In time it may well And what is more important, the value assume similar status among molecular of the project also appears beyond doubt. geneticists. In December 1984, a conference Genome research is revolutionizing biology there, co-sponsored by the U.S. Department and biotechnology, and providing a vital of Energy, pondered a single question: Does thrust to the increasingly broad scope of the modern DNA research offer a way of detect- biological sciences.
    [Show full text]
  • Genomic and Transcriptome Analysis Revealing an Oncogenic Functional Module in Meningiomas
    Neurosurg Focus 35 (6):E3, 2013 ©AANS, 2013 Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas XIAO CHANG, PH.D.,1 LINGLING SHI, PH.D.,2 FAN GAO, PH.D.,1 JONATHAN RUssIN, M.D.,3 LIYUN ZENG, PH.D.,1 SHUHAN HE, B.S.,3 THOMAS C. CHEN, M.D.,3 STEVEN L. GIANNOTTA, M.D.,3 DANIEL J. WEISENBERGER, PH.D.,4 GAbrIEL ZADA, M.D.,3 KAI WANG, PH.D.,1,5,6 AND WIllIAM J. MAck, M.D.1,3 1Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; 2GHM Institute of CNS Regeneration, Jinan University, Guangzhou, China; 3Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; 4USC Epigenome Center, Keck School of Medicine, University of Southern California, Los Angeles, California; 5Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, California; and 6Division of Bioinformatics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California Object. Meningiomas are among the most common primary adult brain tumors. Although typically benign, roughly 2%–5% display malignant pathological features. The key molecular pathways involved in malignant trans- formation remain to be determined. Methods. Illumina expression microarrays were used to assess gene expression levels, and Illumina single- nucleotide polymorphism arrays were used to identify copy number variants in benign, atypical, and malignant me- ningiomas (19 tumors, including 4 malignant ones). The authors also reanalyzed 2 expression data sets generated on Affymetrix microarrays (n = 68, including 6 malignant ones; n = 56, including 3 malignant ones).
    [Show full text]
  • FXYD5: Na+/K+-Atpase Regulator in Health and Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 30 March 2016 doi: 10.3389/fcell.2016.00026 FXYD5: Na+/K+-ATPase Regulator in Health and Disease Irina Lubarski Gotliv * Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel FXYD5 (Dysadherin, RIC) is a single span type I membrane protein that plays multiple roles in regulation of cellular functions. It is expressed in a variety of epithelial tissues and acts as an auxiliary subunit of the Na+/K+-ATPase. During the past decade, a correlation between enhanced expression of FXYD5 and tumor progression has been established for various tumor types. In this review, current knowledge on FXYD5 is discussed, including experimental data on the functional effects of FXYD5 on the Na+/K+-ATPase. FXYD5 modulates cellular junctions, influences chemokine production, and affects cell adhesion. The accumulated data may provide a basis for understanding the molecular mechanisms underlying FXYD5 mediated phenotypes. Keywords: FXYD5, dysadherin, Na+/K+-ATPase, polarity, cell adhesion, cell junctions, glycosylation Edited by: FXYD5 (Dysadherin, RIC) is a type I membrane protein, that belongs to FXYD family. In Olga Vagin, mammalian cells this family of proteins consists of seven members (FXYD1-7) that share the University of California, Los Angeles, conserved F-X-Y-D motif in the trans-membrane domain. All family members are known to USA interact with Na+/K+-ATPase and affect its kinetic properties in a tissue-specific manner (for Reviewed by: a review see Garty and Karlish, 2006). FXYD5 was identified as a cell surface molecule by a Ugo Cavallaro, monoclonal antibody that was developed to selectively recognize cancerous but not normal cells.
    [Show full text]
  • Clinical Significance of P‑Class Pumps in Cancer (Review)
    ONCOLOGY LETTERS 22: 658, 2021 Clinical significance of P‑class pumps in cancer (Review) SOPHIA C. THEMISTOCLEOUS1*, ANDREAS YIALLOURIS1*, CONSTANTINOS TSIOUTIS1, APOSTOLOS ZARAVINOS2,3, ELIZABETH O. JOHNSON1 and IOANNIS PATRIKIOS1 1Department of Medicine, School of Medicine; 2Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus; 3College of Medicine, Member of Qatar University Health, Qatar University, 2713 Doha, Qatar Received January 25, 2021; Accepted Apri 12, 2021 DOI: 10.3892/ol.2021.12919 Abstract. P‑class pumps are specific ion transporters involved Contents in maintaining intracellular/extracellular ion homeostasis, gene transcription, and cell proliferation and migration in all 1. Introduction eukaryotic cells. The present review aimed to evaluate the 2. Methodology role of P‑type pumps [Na+/K+ ATPase (NKA), H+/K+ ATPase 3. NKA (HKA) and Ca2+‑ATPase] in cancer cells across three fronts, 4. SERCA pump namely structure, function and genetic expression. It has 5. HKA been shown that administration of specific P‑class pumps 6. Clinical studies of P‑class pump modulators inhibitors can have different effects by: i) Altering pump func‑ 7. Concluding remarks and future perspectives tion; ii) inhibiting cell proliferation; iii) inducing apoptosis; iv) modifying metabolic pathways; and v) induce sensitivity to chemotherapy and lead to antitumor effects. For example, 1. Introduction the NKA β2 subunit can be downregulated by gemcitabine, resulting in increased apoptosis of cancer cells. The sarco‑ The movement of ions across a biological membrane is a endoplasmic reticulum calcium ATPase can be inhibited by crucial physiological process necessary for maintaining thapsigargin resulting in decreased prostate tumor volume, cellular homeostasis.
    [Show full text]
  • Microarray and Pattern Miner Analysis of AXL and VIM Gene Networks in MDA‑MB‑231 Cells
    MOLECULAR MEDICINE REPORTS 18: 4147-4155, 2018 Microarray and pattern miner analysis of AXL and VIM gene networks in MDA‑MB‑231 cells SUDHAKAR NATARAJAN1, VENIL N SUMANTRAN2, MOHAN RANGANATHAN1 and SURESH MADHESWARAN1 1Department of Biotechnology, Faculty of Engineering and Technology; 2Dr. A.P.J. Abdul Kalam Centre for Excellence in Innovation and Entrepreneurship, Dr. M.G.R. Educational and Research Institute, Tamil Nadu, Chennai 600095, India Received March 20, 2018; Accepted August 2, 2018 DOI: 10.3892/mmr.2018.9404 Abstract. MDA-MB-231 cells represent malignant triple-nega- migration, metastasis and chemoresistance, whereas the VIM tive breast cancer, which overexpress epidermal growth factor gene network regulates novel tumorigenic processes, such as receptor (EGFR) and two genes (AXL and VIM) associated lipogenesis, senescence and autophagy. Notably, these two with poor prognosis. The present study aimed to identify novel networks contain 12 genes not reported for TNBC. therapeutic targets and elucidate the functional networks for the AXL and VIM genes in MDA-MB-231 cells. We identi- Introduction fied 71 genes upregulated in MDA-MB-231 vs. MCF7 cells using BRB-Array tool to re-analyse microarray data from six Triple negative breast cancers (TNBC) lack expression of three GEO datasets. Gene ontology and STRING analysis showed important receptors (ER, PR, and HER2). These cancers account that 43/71 genes upregulated in MDA-MB-231 compared with for 10-15% of breast cancers, and are characterized by overex- MCF7 cells, regulate cell survival and migration. Another pression of epidermal growth factor receptor (EGFR), high 19 novel genes regulate migration, metastases, senescence, proliferative rate, and mutations in the p53 and BRCA1 tumour autophagy and chemoresistance.
    [Show full text]
  • FXYD2 Monoclonal Antibody (M01), Human Gene Nomenclature for the Family Is Clone 1C3-B3 FXYD-Domain Containing Ion Transport Regulator
    FXYD2 monoclonal antibody (M01), human gene nomenclature for the family is clone 1C3-B3 FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). Catalog Number: H00000486-M01 FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. Regulatory Status: For research use only (RUO) FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been Product Description: Mouse monoclonal antibody shown to induce channel activity in experimental raised against a full length recombinant FXYD2. expression systems. Transmembrane topology has been established for two family members (FXYD1 and Clone Name: 1C3-B3 FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. Immunogen: FXYD2 (AAH05302.1, 1 a.a. ~ 64 a.a) The Type III integral membrane protein encoded by this full-length recombinant protein with GST tag. MW of the gene is the gamma subunit of the Na,K-ATPase present GST tag alone is 26 KDa. on the plasma membrane. Although the Na,K-ATPase does not depend on the gamma subunit to be functional, Sequence: it is thought that the gamma subunit modulates the MDRWYLGGSPKGDVDPFYYDYETVRNGGLIFAGLAFI enzyme's activity by inducing ion channel activity. VGLLILLSRRFRCGGNKKRRQINEDEP Mutations in this gene have been associated with renal Host: Mouse hypomagnesaemia. Alternatively spliced transcript variants encoding different isoforms have been found for Reactivity: Human this gene. [provided by RefSeq] Applications: ELISA, IHC-P, S-ELISA, WB-Ce, WB-Re References: (See our web site product page for detailed applications 1.
    [Show full text]
  • Role of Cytochrome C Oxidase Nuclear-Encoded Subunits in Health and Disease
    Physiol. Res. 69: 947-965, 2020 https://doi.org/10.33549/physiolres.934446 REVIEW Role of Cytochrome c Oxidase Nuclear-Encoded Subunits in Health and Disease Kristýna ČUNÁTOVÁ1, David PAJUELO REGUERA1, Josef HOUŠTĚK1, Tomáš MRÁČEK1, Petr PECINA1 1Department of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic Received February 2, 2020 Accepted September 13, 2020 Epub Ahead of Print November 2, 2020 Summary [email protected] and Tomáš Mráček, Department of Cytochrome c oxidase (COX), the terminal enzyme of Bioenergetics, Institute of Physiology CAS, Vídeňská 1083, 142 mitochondrial electron transport chain, couples electron transport 20 Prague 4, Czech Republic. E-mail: [email protected] to oxygen with generation of proton gradient indispensable for the production of vast majority of ATP molecules in mammalian Cytochrome c oxidase cells. The review summarizes current knowledge of COX structure and function of nuclear-encoded COX subunits, which may Energy demands of mammalian cells are mainly modulate enzyme activity according to various conditions. covered by ATP synthesis carried out by oxidative Moreover, some nuclear-encoded subunits possess tissue-specific phosphorylation apparatus (OXPHOS) located in the and development-specific isoforms, possibly enabling fine-tuning central bioenergetic organelle, mitochondria. OXPHOS is of COX function in individual tissues. The importance of nuclear- composed of five multi-subunit complexes embedded in encoded subunits is emphasized by recently discovered the inner mitochondrial membrane (IMM). Electron pathogenic mutations in patients with severe mitopathies. In transport from reduced substrates of complexes I and II to addition, proteins substoichiometrically associated with COX were cytochrome c oxidase (COX, complex IV, CIV) is found to contribute to COX activity regulation and stabilization of achieved by increasing redox potential of individual the respiratory supercomplexes.
    [Show full text]
  • Anti-FXYD5 (Aa 164-178) Polyclonal Antibody (CABT-BL1575) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-FXYD5 (aa 164-178) polyclonal antibody (CABT-BL1575) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Immunogen Synthetic peptide: GKCRQLSRLCRNHCR, corresponding to C terminal amino acids 164-178 of Human Dysadherin. Isotype IgG Source/Host Goat Species Reactivity Human Purification IgG fraction Conjugate Unconjugated Applications WB Cellular Localization Cell Membrane; Single-pass type I membrane protein Format Liquid Buffer 0.5% BSA, Tris buffered saline, pH 7.3 Preservative 0.02% Sodium Azide Storage Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. BACKGROUND Introduction This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane.
    [Show full text]
  • Human Primitive Brain Displays Negative Mitochondrial-Nuclear Expression Correlation of Respiratory Genes
    Downloaded from genome.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Research Human primitive brain displays negative mitochondrial-nuclear expression correlation of respiratory genes Gilad Barshad, Amit Blumberg, Tal Cohen, and Dan Mishmar Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel Oxidative phosphorylation (OXPHOS), a fundamental energy source in all human tissues, requires interactions between mitochondrial (mtDNA)- and nuclear (nDNA)-encoded protein subunits. Although such interactions are fundamental to OXPHOS, bi-genomic coregulation is poorly understood. To address this question, we analyzed ∼8500 RNA-seq exper- iments from 48 human body sites. Despite well-known variation in mitochondrial activity, quantity, and morphology, we found overall positive mtDNA-nDNA OXPHOS genes’ co-expression across human tissues. Nevertheless, negative mtDNA- nDNA gene expression correlation was identified in the hypothalamus, basal ganglia, and amygdala (subcortical brain re- gions, collectively termed the “primitive” brain). Single-cell RNA-seq analysis of mouse and human brains revealed that this phenomenon is evolutionarily conserved, and both are influenced by brain cell types (involving excitatory/inhibitory neu- rons and nonneuronal cells) and by their spatial brain location. As the “primitive” brain is highly oxidative, we hypothesized that such negative mtDNA-nDNA co-expression likely controls for the high mtDNA transcript levels, which enforce tight OXPHOS regulation, rather than rewiring toward glycolysis. Accordingly, we found “primitive” brain-specific up-regula- tion of lactate dehydrogenase B (LDHB), which associates with high OXPHOS activity, at the expense of LDHA, which pro- motes glycolysis. Analyses of co-expression, DNase-seq, and ChIP-seq experiments revealed candidate RNA-binding proteins and CEBPB as the best regulatory candidates to explain these phenomena.
    [Show full text]
  • Renoprotective Effect of Combined Inhibition of Angiotensin-Converting Enzyme and Histone Deacetylase
    BASIC RESEARCH www.jasn.org Renoprotective Effect of Combined Inhibition of Angiotensin-Converting Enzyme and Histone Deacetylase † ‡ Yifei Zhong,* Edward Y. Chen, § Ruijie Liu,*¶ Peter Y. Chuang,* Sandeep K. Mallipattu,* ‡ ‡ † | ‡ Christopher M. Tan, § Neil R. Clark, § Yueyi Deng, Paul E. Klotman, Avi Ma’ayan, § and ‡ John Cijiang He* ¶ *Department of Medicine, Mount Sinai School of Medicine, New York, New York; †Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; ‡Department of Pharmacology and Systems Therapeutics and §Systems Biology Center New York, Mount Sinai School of Medicine, New York, New York; |Baylor College of Medicine, Houston, Texas; and ¶Renal Section, James J. Peters Veterans Affairs Medical Center, New York, New York ABSTRACT The Connectivity Map database contains microarray signatures of gene expression derived from approximately 6000 experiments that examined the effects of approximately 1300 single drugs on several human cancer cell lines. We used these data to prioritize pairs of drugs expected to reverse the changes in gene expression observed in the kidneys of a mouse model of HIV-associated nephropathy (Tg26 mice). We predicted that the combination of an angiotensin-converting enzyme (ACE) inhibitor and a histone deacetylase inhibitor would maximally reverse the disease-associated expression of genes in the kidneys of these mice. Testing the combination of these inhibitors in Tg26 mice revealed an additive renoprotective effect, as suggested by reduction of proteinuria, improvement of renal function, and attenuation of kidney injury. Furthermore, we observed the predicted treatment-associated changes in the expression of selected genes and pathway components. In summary, these data suggest that the combination of an ACE inhibitor and a histone deacetylase inhibitor could have therapeutic potential for various kidney diseases.
    [Show full text]